Shuxing Zhang received his Ph.D. degree from the School of Pharmacy at the University of North Carolina at Chapel Hill in 2005, and then he worked as a Research Scientist for the US Department of Defense. His research is focused on drug discovery and development with state-of-the-art computational and informatics technologies. Dr. Zhang currently is an Assistant Professor at the Department of Experimental Therapeutics at MD Anderson Cancer Center and the Director of Molecular Modeling and Structural Biology Core facility. He has been serving as an editor and reviewer for several journals, and he is the recipient of ACS Hewlett-Packard Junior Faculty Award and Chemical Computing Group (CCG) Excellence Award. In 2009, he cofounded PHusis Therapeutics, Inc. based on their development of pleckstrin homology (PH) domain inhibitors for various cancer treatment. Dr. Zhang also provides consulting services in drug discovery and is actively involved in the scientific community through ACS, AAPS, and IEEE.
Biography Updated on 16 August 2011